MedTrace Logo

Biomarkers for Diagnosis of Lung Cancer

NCT02050100 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-05-12

No results posted yet for this study

Summary

The study goal is to collect blood samples from individuals at risk for lung cancer in order to identify protein markers for diagnosis of lung cancer in the Chinese population.

Conditions

Sponsors & Collaborators

  • SK Medical (Beijing) Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chunxue Bai, M.D, Ph.D. · Zhongshan Hospital Fudan Universit

  • Xiaoju Zhang, M.D. · Henan Provincial People's Hospital

  • Muyun Zhu, M.D. · Northern Jiangsu People's Hospital

  • Kai Wang, MD · The Second Affliated Hospital of Zhejiang University School of Medicine

  • Zuke Xiao, MD · Jiangxi Provincial People's Hopital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-10-31
Completion
2015-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02050100 on ClinicalTrials.gov